One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papershttps://doi.org/10.1016/s0090-8258(22)01258-6
Copy DOI Journal: Gynecologic Oncology |  Publication Date: Aug 1, 2022 |
 Citations: 1 |
Affiliation: University of Oklahoma Health Sciences Center, Tennessee Oncology, Sarah Cannon, Dartmouth–Hitchcock Medical Center, Cotton (United States), Western Pennsylvania Hospital, Florida Cancer Specialists & Research Institute, University of Washington, GlaxoSmithKline (United States), Riverside Methodist Hospital, University of California, Los Angeles, Alaska Women's Cancer Care, University of RochesterOVARIO, A Phase 2 Study of Niraparib + Bevacizumab in Advanced Ovarian Cancer Following Front-Line Platinum-Based Chemotherapy with Bevacizumab: Updated Analysis (039)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
